Related Experiment Video
Updated: Nov 3, 2025
11:34
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.4K
Functional cure for chronic hepatitis B: accessibility, durability, and prognosis.
Aixin Song1, Xiao Lin1, Xinyue Chen2
1First Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Virology Journal
|June 4, 2021
Summary
Hepatitis B surface antigen (HBsAg) clearance is a key treatment goal, though rates are low. New strategies improve clearance, and researchers focus on long-term outcomes after HBsAg loss.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis B surface antigen (HBsAg) clearance is the ideal endpoint for antiviral therapy, offering safe drug withdrawal and improved prognosis.
- However, achieving HBsAg clearance remains challenging, with low overall rates influenced by treatment modality and duration.
Purpose of the Study:
- To review the current landscape of Hepatitis B surface antigen (HBsAg) clearance.
- To discuss the accessibility, durability, and prognostic improvements associated with HBsAg clearance.
- To highlight recent advances in strategies aimed at achieving HBsAg clearance.
Main Methods:
- Review of existing literature on antiviral treatment strategies for Hepatitis B.
- Analysis of data regarding HBsAg clearance rates with various treatment approaches.
- Examination of studies focusing on the long-term outcomes and durability post-HBsAg clearance.
Main Results:
- Combined and extended antiviral treatment strategies have shown promise in improving HBsAg clearance rates.
- Several patients have successfully achieved HBsAg clearance in clinical settings.
- The durability and clinical outcomes following HBsAg clearance are areas of active investigation.
Conclusions:
- Achieving HBsAg clearance is a significant milestone in Hepatitis B management.
- Further research is needed to optimize treatment strategies and understand long-term benefits.
- Focus on accessibility, durability, and prognostic impact is crucial for advancing Hepatitis B care.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
50
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
50
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
44
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
44
01:10Retrovirus Life Cycles
48.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.0K
01:29Chronic Pancreatitis II: Collaborative Care
152
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
152
01:17Chronic Bowel Disorders: Introduction
588
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
588
01:26Diseases of the Liver and Gallbladder
1.5K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.5K